查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球神經假體市場-2022-2029
市場調查報告書
商品編碼
1140760

全球神經假體市場-2022-2029

Global Neuroprosthetics Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

預計神經假體的市場規模在預測期間（2022-2029 年）將以 12.2% 的複合年增長率增長。

神經假體是神經科學和生物醫學工程的一個分支，涉及神經假體的開發。這些是一系列可以替代因受傷或疾病而受損的運動、感覺、認知和其他功能的設備。

市場動態

全球神經假體市場正在增長，這得益於多種因素，例如患有神經系統疾病和損傷的患者人數增加、糖尿病患病率增加、聽力損失發生率增加以及設備技術進步。

神經假體的不斷進步和對神經假體的日益增長的需求正在推動全球市場的增長。

神經假體的進步和發展正在推動市場的增長。例如，ABBOT 的 DRG（背根神經節）療法有助於治療 I 型和 II 型複雜區域疼痛綜合徵 (CRPS) 成人患者下肢嚴重慢性頑固性疼痛以及人工關節相關的慢性疼痛。或兩者兼而有之，這種療法使用溫和的電信號來治療慢性疼痛。而由 Neurospace, Inc. 開發的 RNS 系統是唯一獲得 FDA 批准的癲癇治療設備，它可以響應異常的大腦活動並跟蹤 EEG 數據以提供個性化的治療和患者護理。它幫助我改進。此外，波士頓科學公司還推出了 Vercise DBS，這是一種具有精確神經靶向的神經假體，可以為帕金森病、原發性和繼發性肌張力障礙、特發性震顫患者提供個性化治療，也是該設備的最早開發公司。此外，創傷性腦損傷和神經系統疾病的增加正在推動全球市場的增長。例如，在過去 30 年中，大約有三分之一的人會在其生命的某個階段患有神經系統疾病，而死於神經系統疾病的人數增加了近 40%。每年大約有 20 到 5000 萬人因交通事故而遭受非致命傷害，據說其中大多數人患有某種神經系統疾病。

此外，每年約有 20 到 5000 萬人因道路交通事故而遭受非致命傷害，其中大多數人患有某種形式的神經損傷。

但是，設備的高成本阻礙了市場增長。神經假體是一種新興的聽力障礙治療選擇，這使得它們非常昂貴，尤其是在發展中國家。人工耳蝸、視覺和海馬（或認知）等神經假體通常非常昂貴，因此大多數患者無法使用。

行業分析

全球神經假體市場報告基於波特五力、創新、新產品發布和定價等各種行業因素對市場進行了深入分析。

COVID-19 影響分析

在 COVID-19 期間，由於供應鏈中斷、市場上原材料稀缺以及大多數研究機構和大學關閉，全球研發項目被擱置。此外，大流行期間常規醫療保健檢查的困難以及旅行和社交的限制使大多數患有神經系統疾病的患者未被發現。

細分分析

在預測期內（2022-2029 年），輸出型神經假體有望主導全球市場。

輸出神經假體包括認知假體和人工耳蝸。輸出型神經假體將在 2021 年佔據最大的市場份額。輸入神經假體包括仿生眼/視網膜植入物。由於滲透率的提高和產品創新研發力度的加大，預計視網膜植入物在預測期內將以最快的速度增長。例如，對於人工耳蝸，每年要花費數百萬美元來實現更強大、更有效的聽力治療方案。例如，在人工耳蝸的情況下，已經努力通過電極設計更好地保護內耳的神經結構，並通過佩戴在雙耳上的設備聯網提供更自然的聽覺體驗。此外，我們正致力於通過利用人工智能和引入新的信號處理算法來改善聽覺體驗，並開發使用應用程序的遠程控制。

區域分析

據估計，北美將主導全球神經假體市場。

由於腦外傷發病率高、老年人口不斷增加以及研發投資增加，北美地區擁有世界神經假體的主要部分。例如，根據疾病預防控制中心的數據，2020 年約有 64,362 人死亡，其中每天有 611 人因腦外傷而住院和 176 人死亡。 CDC 提供的這些統計數據不包括急診科、初級保健、緊急護理或未經治療的創傷性腦損傷。 75 歲及以上的患者在創傷性腦損傷中的數量和發生率最高。因此，北美日益增長的老年人口也是使北美主導全球市場的一個因素。例如，根據人口事務研究所的統計數據，從人口普查局 2020 年的人口中推斷，超過 5500 萬美國人年齡在 65 歲及以上。此外，研發投資的增加、政府和私人機構的資金增加以及神經植入物製造商的大量存在正在推動該地區的市場增長。例如，美國國防高級研究計劃局 (DARPA) 和美國國家神經疾病和中風研究所 (NIH) 正在與聯邦機構合作，提供資金來支持研發計劃，以進一步開發神經植入物。

競爭格局

神經假體市場競爭激烈，少數主要參與者爭奪市場份額。全球神經假體市場的主要參與者包括波士頓科學、美敦力、雅培、Cochlear、LivaNova、Sonova、Retina Implant、Med-El、Neuropace 和 NDI Medical 等。主要參與者採取了各種增長戰略，如產品發布、併購、合作夥伴和合作，為全球神經假體市場的增長做出了貢獻。例如，2022 年 8 月 31 日，美敦力與 BioIntelliSense 合作，獲得了多參數可穿戴設備的美國獨家商業權利，用於從醫院到家庭的連續遠程患者監測。此外，2022 年 8 月 30 日，美敦力收購了 Afera。

概述：

Medtronic PLC 是一家總部位於愛爾蘭的美國醫療設備製造商。美敦力公司成立於 1949 年，總部位於美國明尼蘇達州明尼阿波利斯市。美敦力經營四項業務：微創治療組、糖尿病組、恢復性治療組和心血管組。

產品組合

Medtronic plc 的神經修復產品組合包括 Percept PC DBS 系統、Activa RC 系統、SenSight Directional Leads、VANTA PC Neurostimulator、INTELLIS Neurostimulator、Primeadvanced Surescan MRI Neurostimulator 和 Restore。

全球神經假體市場報告將提供對大約 40 多個市場數據表、45 多個圖表和 200 多個頁面（大約）的訪問。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 創新與發展
      • 對神經假體的需求不斷增長
    • 限制因素
      • 高成本
      • 缺乏熟練的專業人員
    • 商機
    • 影響分析

第5章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 輸出神經假體
    • 機車假肢
    • 認知功能假體
  • 輸入神經假體
    • 人工耳蝸
    • 人工耳蝸/視網膜植入物

第 8 章技術

  • 脊髓刺激療法
  • 深層腦刺激療法
  • 迷走神經刺激
  • 經顱磁刺激
  • □神經刺激
  • 其他

第 9 章。按應用程序

  • 生理障礙
    • 聽覺信息處理障礙
    • 眼科疾病
    • 循環區
    • 泌尿科
  • 運動神經元疾病
    • 帕金森病
    • 癲癇
  • 認知障礙專業化
    • 阿爾茨海默氏症
    • 癱瘓

第 10 章，最終用戶

  • 醫院
  • 專門的神經外科設施
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準

第 13 章公司簡介

  • 美敦力公司
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Boston Scientific
  • Abbott
  • Cochlear
  • LivaNova
  • Sonova
  • Retina Implant
  • Med-El
  • Neuropace
  • NDI Medical

第14章 DataM

簡介目錄
Product Code: DMMD2173

Market Overview

Neuroprosthetics Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 12.2% during the forecast period (2022-2029).

Neuroprosthetics (neural prosthetics) is a branch of neuroscience and biomedical engineering concerned with developing neural prostheses. These are a series of devices that can substitute for the functions of a motor, sensory, or cognitive modality that may have been damaged because of an injury or a disease.

Market Dynamics

The global neuroprosthetics market is growing due to several factors, such as the rising number of patients suffering from neurological disorders and nerve injuries, the growing prevalence of diabetes, the increasing incidence of hearing loss, and technological advancements in the devices.

The rising advancements in neuroprosthetics and the growing need for neuroprosthetics are fueling global market growth.

The advancements and developments in neuroprosthetics are fueling market growth. For instance, DRG (Dorsal Root Ganglion) therapy by ABBOT helps in treating chronic pain associated with severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome (CRPS) types I and II post-amputation or both prosthetic implant; this therapy acts by using mild electrical signals to treat chronic pain. Furthermore, the RNS system developed by Neurospace is the only FDA-approved epilepsy device that provides personalized treatment by responding to abnormal brain activity and tracking EEG data which helps in improving patient care. Moreover, Boston Scientific is the first to engineer a neuroprosthetic called Vercise DBS for accurate neural targeting allowing personalized therapy for patients with Parkinson's disease, primary and secondary dystonia, and essential tremor. In addition, the growing incidences of traumatic brain injuries and neurological diseases are fueling the global market growth; for instance, around 1 in 3 people have been affected by a neurological disease at some point in their life over the past 3 decades, and the neurological disorder deaths have increased by almost 40%; also, around 20-50 million people yearly suffer from non-fatal injuries road crashes majority of which suffer from some neurological damage.

The high cost will hamper the global market growth.

However, the high cost of the devices hinders the market's growth. Neuroprosthetics is an emerging treatment option for hearing damage, which makes them very expensive, especially in developing countries. Neuroprosthetics such as cochlear, visual, and hippocampal (or cognition) prostheses are generally very expensive and make it difficult for most patients to access.

Industry analysis.

The global neuroprosthetics market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, Etc.

COVID-19 Impact Analysis

The supply chain was disrupted during COVID-19, which caused a lack of raw materials in the market, putting global research and development projects on hold as most of the research institutes and universities were shut down. Moreover, regular healthcare check-ups were difficult amidst the pandemic, leaving most patients with undetected neurological disorders because of the travel and socializing restrictions; there was a reduction in road and traffic injuries reducing the cases of traumatic brain injury, and overall impacting the neuroprosthetics market.

Segment Analysis

The output neural prosthetics are predicted to dominate the global market during the forecast period (2022-2029).

The output neural prosthetics include cognitive prosthetics and cochlear implants. The output neural prosthetics accounted for the largest market share in 2021. The input neural prosthetics include bionic eye/retinal implants. Retinal implants are estimated to grow at the fastest growth rate during the forecast period, owing to the rising penetration and the increasing R&D efforts for product innovation. For instance, in the case of cochlear implants, millions of dollars are being spent every year to achieve even more powerful and effective hearing treatment options. These efforts include better preserving the neural structures in the inner ear through electrode design and bringing a more natural hearing experience through networking the devices worn on both ears. Furthermore, work on ways to improve the hearing experience through the argumentation of artificial intelligence and the introduction of new signal processing algorithms, as well as to develop app-based remote controls.

Geographical Analysis

North America is estimated to subjugate the global Neuroprosthetics market.

The North American region holds the major part of the global Neuroprosthetics Since there are high incidences of traumatic brain injuries, a growing geriatric population, and increasing R&D investments. For instance, according to the CDC data, around 64,362 deaths in 2020 were claimed by traumatic brain injury, making up 611 hospitalizations and 176 deaths daily to traumatic brain injury as the cause. These statistics CDC provided exclude the traumatic brain injuries treated in emergency departments, primary care, urgent care or untreated ones. Patients aged 75 and older were the ones that accounted for the highest number and rates of traumatic brain injuries. Therefore, the growing geriatric population in North America is also a contributing factor to North America's command over the global market. For instance, according to statistics from The Population Reference Bureau, over 55 million Americans are 65 or older, per the estimate from the Census Bureau's 2020 population. In addition, increasing R&D investments, growing funding from government and private institutes, and the large presence of neural implant manufacturers drive market growth in this region. For instance, the Defense Advanced Research Project Agency (DARPA) and National Institute of Neurological Disorders and Stroke (NIH), in collaboration with federal agencies, are instrumental in providing funds to support R&D initiatives for the further development of neural implants.

Competitive Landscape

The neuroprosthetics market is competitive, with few major players competing to gain market share. Some major players in the global neuroprosthetics market include Boston Scientific, Medtronic, Abbott, Cochlear, LivaNova, Sonova, Retina Implant, Med-El, Neuropace, and NDI Medical, among others. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations contributing to the growth of the neuroprosthetics market globally. For instance, AUG 31, 2022, Medtronic partnered with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearables for continuous remote patient monitoring from in-hospital to home. Also, AUG 30, 2022, Medtronic acquired Affera.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

Medtronic plc's product portfolio for neuroprosthetics has Percept PC DBS System, Activa RC system, SenSight Directional Leads, VANTA PC Neurostimulator, INTELLIS Neurostimulator, Primeadvanced Surescan MRI Neurostimulator, and Restore.

The global neuroprosthetics market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations and Developments
      • 4.1.1.2. The Growing Need For Neuroprosthetics
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
      • 4.1.2.2. Lack of Skilled Professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Output Neural Prosthetics
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Motor Prosthetics
    • 7.2.4. Cognitive Prosthetics
  • 7.3. Input Neural Prosthetics
    • 7.3.1. Cochlear Implants
    • 7.3.2. BImplants/Retinal Implants

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
    • 8.1.2. Market Attractiveness Index, By Technology Segment
  • 8.2. Spinal Cord Stimulation
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Deep Brain Stimulation
  • 8.4. Vagus Nerve Stimulation
  • 8.5. Transcranial magnetic Stimulation
  • 8.6. Sacral Nerve Stimulation
  • 8.7. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Physiological Disorders
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 9.2.3. Auditory Processing Disorders
    • 9.2.4. Ophthalmic Disorders
    • 9.2.5. Cardiovascular Disorders
    • 9.2.6. Urology Disorder
  • 9.3. Motor Neuron Disorders
    • 9.3.1. Parkinson's Disease
    • 9.3.2. Epilepsy
  • 9.4. Cognitive Disorders Specialized
    • 9.4.1. Alzheimer's Disease
    • 9.4.2. Paralysis

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Specialized Neurosurgery Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Medtronic Plc
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Boston Scientific
  • 13.3. Abbott
  • 13.4. Cochlear
  • 13.5. LivaNova
  • 13.6. Sonova
  • 13.7. Retina Implant
  • 13.8. Med-El
  • 13.9. Neuropace
  • 13.10. NDI Medical

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us